AONC (American Oncology Network) Retained Earnings: $-102 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AONC American Oncology Network Inc AONC
20 GF Score
Price $12.00
View Full Analysis

What is American Oncology Network Retained Earnings?

American Oncology Network AONC +20.00% 20 Retained Earnings is $-102 Mil as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. American Oncology Network's retained earnings for the quarter that ended in Dec. 2024 was $-102 Mil.

American Oncology Network's quarterly retained earnings declined from Jun. 2024 ($-67 Mil) to Sep. 2024 ($-103 Mil) but then increased from Sep. 2024 ($-103 Mil) to Dec. 2024 ($-102 Mil).

American Oncology Network's annual retained earnings declined from Dec. 2022 ($26 Mil) to Dec. 2023 ($-162 Mil) but then increased from Dec. 2023 ($-162 Mil) to Dec. 2024 ($-102 Mil).


American Oncology Network  (OTCPK:AONC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


American Oncology Network Retained Earnings Historical Data

* Premium members only.

The historical data trend for American Oncology Network's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network Retained Earnings Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
0.00 23.24 25.83 -161.81 -102.17

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -161.81 -175.59 -66.72 -103.49 -102.17
AONC
20GF Score
American Oncology Network Inc AONC
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Oncology Network Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-102 Mil mean?
American Oncology Network (AONC) has a Retained Earnings of $-102 Mil as of Dec. 2024. Retained earnings is the amount of net income not issued to shareholders. View historical data on American Oncology Network and its competitors.
Is American Oncology Network's Retained Earnings too high?
American Oncology Network's current Retained Earnings is $-102 Mil. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's Retained Earnings compare to TOI and AUNA?
American Oncology Network's Retained Earnings of $-102 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on American Oncology Network and its competitors. American Oncology Network's current Retained Earnings is $-102 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current Retained Earnings of $-102 Mil. The current Retained Earnings is $-102 Mil. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For American Oncology Network (AONC), the current Retained Earnings is $-102 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.00
Price